Evidence map›Paper›PMID 36750811›Full record

ArticleBMC public health2023

Assessment of an instrument scale measuring the knowledge of antiretroviral therapy among people living with HIV.

Di Xu, Yuhua Shi, Ling Pan, Qiongli Duan, Nengmei Huang, Pengcheng Liu, Jing Han, Zhongfu Liu, Jian Li, Hongjie Liu

Abstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Di Xu *National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, 102206, Beijing, People's Republic of China.
Yuhua Shi *Yunnan Center for Disease Control and Prevention, Kunming, People's Republic of China.
Ling PanNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, 102206, Beijing, People's Republic of China.
Qiongli DuanCenter for Disease Control and Prevention in Honghe Hani and Yi Autonomous Prefecture, Mengzi, People's Republic of China.
Nengmei HuangCenter for Disease Control and Prevention in Honghe Hani and Yi Autonomous Prefecture, Mengzi, People's Republic of China.
Pengcheng LiuNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, 102206, Beijing, People's Republic of China.
Jing HanNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, 102206, Beijing, People's Republic of China.
Zhongfu LiuNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, 102206, Beijing, People's Republic of China.
Jian LiNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, 102206, Beijing, People's Republic of China. jli@chinaaids.cn.ORCID 0000-0003-2799-0051
Hongjie LiuDepartment of Epidemiology and Biostatistics, School of Public Health, University of Maryland, College Park, MD, USA.ORCID 0000-0001-5733-4309

Funding

National Natural Science Foundation of China 71774150National Natural Science Foundation of China 72164040Young School Scientific Research Foundation of NCAIDS, Chibese Center for Disease Control and Prevention China 2108AFQN004
6 · The paper itself

Abstract

backgroundAntiretroviral therapy (ART) is currently the most effective way to treat people living with human immunodeficiency virus (PLHs) and reduce HIV transmission. While there are many factors that reduce adherence to ART, PLHs' knowledge about ART may determine the level of adherence. It is necessary to design and assess an instrument scale that measures the knowledge of antiretroviral therapy among PLHs.

methodA cross-sectional study was conducted among PLHs in Honghe Hani and Yi Autonomous Prefecture, China. Both exploratory and confirmatory factor analyses were used to examine the latent factors of antiretroviral therapy knowledge scale. Internal consistency was assessed separately for the scale and its dimensions by estimating Cronbach's alphas, split-half reliability and Spearman's correlation coefficient. ANOVAs were used to compare the scores of different dimensions with sociodemographic characteristics.

resultsFour factors were extracted according to factor loadings. They had high internal consistency reliability (Cronbach's alpha: 0.70-0.95) and good construct validity (standardized factor loading range: 0.46-0.86) in the scale. Goodness of fit indices indicated that a four-factor solution fit the data at an accepted level (χ

conclusionThe psychometric assessment indicated that this ART knowledge scale had accepted internal consistency and discriminant construct validity. It can be used to assess the knowledge of antiretroviral therapy for PLHs.

Indexed as

HIVHIV InfectionsCross-Sectional StudiesHumansPsychometricsReproducibility of ResultsSurveys and QuestionnairesInstrument scaleKnowledge of antiretroviral therapyPsychometric assessment

Identifiers

PMID36750811
PMCPMC9906841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.